Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on Vaccinated Immune Attacks

Abstract

Yang I Pachankis

Background: The research reports on a medical case of SARS-CoV-2 vaccinated patient. With the SARS-CoV’s Spike 2 (S2) protein sharing similar helix structure with HIV-1 gp41, the patient experienced severe immune system responses one year after the third dose of Kexing recombined vaccines.

Methods: The author conceived a medicine induced hemodialysis technique according to the patient’s symptoms, and im- plemented after emergent treatments. Indicators from the patient’s emergent treatments corroborate with the initial prescrip- tion’s validity.

Results: The clinical case validates the medicine induced hemodialysis method in treating SARS-CoV(-2)-related early symptoms in reducing irreversible damages to humans, depending on individual clinical cases.

Conclusions: The clinical case along with literature review suggests SARS-CoV series are compound virus unlikely from natural origins. It is inferred to have spread in mainland China at least back to the 1990s, and possibly a result from nuclear tests. The downplay of SARS-CoV-2’s S2 protein and epidemiological varieties could have led to the global vaccine man- dates, and the damages to human immune system need to be further researched into. The research concludes that SARS-CoV evidenced PRC’s transgressions to the 1948 Geneva Conventions, which is the reason that the regime and its ruling party are systematically and willfully lying to the society and global institutions.

PDF